<DOC>
	<DOCNO>NCT01054651</DOCNO>
	<brief_summary>The purpose study determine comparative efficacy artesunate plus sulfamethoxypyrazine-pyrimethamine versus Praziquantel treatment school child infect S.mansoni western Kenya .</brief_summary>
	<brief_title>A Randomised Trial Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel Treatment S. Mansoni</brief_title>
	<detailed_description>Schistosomiasis remain important parasitic disease tropic , include Kenya . In absence vaccine , major control strategy reduction morbidity chemotherapy use Praziquantel . Evidence laboratory study field trial continue show schistosome worm develop reduced susceptibility Praziquantel . These observation indicate need research monitor trend efficacy praziquantel need research develop novel antischistosomal drug . Randomized controlled trial also show Artemisinin derivative ( artesunate , artemether ) antischistosomal activity S. mansoni , S. haematobium S. japonicum . We propose conduct open-label , randomize trial evaluate comparative efficacy artesunate plus sulfamethoxypyrazine-pyrimethamine versus Praziquantel treatment 212 school child infect S.mansoni Rarieda district western Kenya . To screen 1000 school child examination stool schistosome egg . Eligible child randomize receive either artesunate plus sulfamethoxypyrazine-pyrimethamine 3 day single dose Praziquantel . Four week treatment , participant assess cure egg reduction.Our study may provide vital information regard alternative treatment S. mansoni infection child .</detailed_description>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Sulfalene</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Aged 6 15 year old Study participant appear healthy enrollment , assess study clinician Suffering S. mansoni infection , excrete egg stool Residing Uyoma area , near Lake Victoria Able receive oral treatment Parent/legal guardian give inform write consent child participate study Child assent participate study Weighing 50 kg Pregnant lactating time study Presence infection Plasmodium falciparum Plasmodium spp . Presence severe illness , cerebral cysticercosis Signs severe malnutrition ( defined child weight/height ratio 3 standard deviation 70 % median WHO standardize reference value , still symmetrical oedema affect foot ) Hypersensitivity As , sulfonamides PZQ . Use another antimalaria antischistosomal drug study , within 28 day administration treatment . Previous participation study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Schistosoma mansoni</keyword>
	<keyword>Praziquantel</keyword>
	<keyword>Artesunate + Sulfamethoxypyrazine/pyrimethamine</keyword>
	<keyword>Randomized open-label control clinical trial</keyword>
</DOC>